Skip to main content

Follow us

Home

Search

the Gateway to Research in Oklahoma

  • Researchers
  • Providers
  • Patients
  • About GRO

Gateway to Research in Oklahoma


Oklahoma Shared Clinical and Translational Resources U54 GM104938

Researchers

imgResearchers

The GRO: Researcher Portal provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in Oklahoma.

Providers

imgProviders

The GRO: Provider Portal assists medical providers to identify clinical research opportunities in Oklahoma, tools for patient education, and evidence-based resources to improve patient care.

Patients

imgPatients

The GRO: Patient Portal can help patients and families to learn more about clinical and translational research and to connect with opportunities to participate in research opportunities in your communities.

Oklahoma Research Highlights

Glycaemic Control According to the Final Insulin Dose Using an Innovative Fixed-Dose Titration of Weekly Insulin Efsitora in Insulin-Naïve Type 2 Diabetes

1 day 16 hours ago
CONCLUSIONS: In QWINT-1, the innovative fixed-dose efsitora simple titration resulted in effective HbA1c lowering for all fixed doses. Rates of clinically meaningful hypoglycaemia were low after fixed-dose increases.
Lisa Connery

In case you missed it: THT 2026

1 day 16 hours ago
No abstract
Alexander G Hajduczok

Selenium in the Preterm Infant: Are We Supplementing Enough in This Vulnerable Population?

16 hours 9 minutes ago
Selenium (Se) is an essential trace element. The bioactivity of Se arises from its incorporation into the 21st amino acid, selenocysteine (Sec). Twenty-five human genes have been identified that encode selenoproteins, each of which contains at least one Sec residue. Selenoprotein functions include antioxidant responses, thyroid hormone synthesis, and maintenance of cellular redox homeostasis. Due to its role in critical cellular functions, Se deficiency is associated with morbidities of the...
Jeffrey V Eckert

OH-MEMA: An Integrated One Health Mixed-Effects Modeling Approach for Syndromic Surveillance

16 hours 9 minutes ago
Background/Objectives: Integrating heterogeneous One Health time series into transparent and usable surveillance workflows remains difficult because data preparation, modeling, and interpretation are often separated across tools. In this paper, we introduce OH-MEMA (One Health Mixed-Effects Modeling and Analytics), an interactive visual analytics framework that integrates heterogeneous One Health data streams, including human clinical outcomes, environmental factors, and wastewater surveillance...
Aseel Basheer

Maternal <em>RFC1</em> Gene Polymorphisms and Neural Tube Defects: A Case-Control Study in Ethiopia

16 hours 9 minutes ago
CONCLUSIONS: This study did not reveal significant association between maternal RFC1 gene polymorphisms and NTD-affected births. Comprehensive whole-genome sequencing of affected off-spring is essential to identify specific mutations or polymorphisms that may individually or collaboratively affect the risk of NTDs in the Ethiopian context.
Hasset Tamirat Molla

Pagination

  • Previous page ‹ Previous
  • Page 217
  • Next page Next ›
Subscribe to

octsi logo

1000 N. Lincoln Blvd, Suite 2100, Oklahoma City, OK 73104
Copyright © 2021 The Board of Regents of the University of Oklahoma, All Rights Reserved.

About GRO

News
Publications
FAQ

Terms of Use

Privacy Policy
Accessibility

Contact

info email
info phone
Copyright © 2026. All rights reserved. Designed By Zymphonies